What severity of hidradenitis suppurativa is Humira (adalimumab) indicated to treat in adults and adolescents aged 12 years or older after an inadequate response to conventional systemic therapy?

Humira (adalimumab) is indicated for active moderate to severe hidradenitis suppurativa in adults and adolescents aged 12 years or older with an inadequate response to conventional systemic HS therapy.